Rethinking HEOR Market Access Integration: A Ca...

By João L. Carapinha

November 24, 2025

Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must o...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line The...
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
HIV Therapy Advancements: Promising Results from Bictegravir/Lenacapavir Comb...
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
Weight Loss: Advances in Hormone-Based Obesity Treatments
Beta-Blockers in Heart Attack Recovery: Reevaluating Their Role Based on Rece...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Advancing Kidney Transplant Transparency Through Patient Involvement
Obesity Health Economics: Forecasting Trends and Costs in the US
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...